Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2013		Sep. 23, 2012
Cash flows from operating activities:
Net loss	$ (11,733)		$ (110,841)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	21,315		25,184
Deferred taxes	(228)		(967)
Stock-based compensation	5,145		3,737
Provision for losses on accounts receivable	(638)		3,400
Excess tax benefit on stock compensation	(594)		(97)
Loss (gain) on disposal of fixed assets	343		(1,069)
Litigation settlement	(6,584)		0
Intangible impairment	0		1,442
Goodwill impairment	0		64,807
Gain on sale of subsidiary	(248)		0
Loss on sale of discontinued operations	13,043		0
Restructuring related asset impairment	731		6,156
Decrease (increase) in current assets, net of the effects of acquired companies:
Accounts receivable	25,020		32,875
Inventories	(12,514)		19,634
Other current assets	(3,824)		633
Decrease in current liabilities, net of the effects of acquired companies:
Accounts payable	(2,604)		(4,562)
Income taxes	(1,950)		(3,319)
Unearned revenues	(8,139)		(10,143)
Restructuring reserve	(5,923)		(1,983)
Other current and accrued liabilities	(14,825)		(3,696)
Net cash (used in) provided by operating activities	(4,207)		21,191
Cash flows from investing activities:
Acquisition of property, plant, and equipment and intangibles	(5,955)		(10,415)
Change in restricted cash	0		291
Proceeds from sale of real estate	0		(4,560)
Cash proceeds from the sale of discontinued operations	1,502		0
Cash proceeds from the sale of subsidiary	227		0
Other investing activities	1,151		1,148
Net cash used in investing activities	(3,075)		(4,416)
Cash flows from financing activities:
Proceeds from stock issuances	2,980		922
Excess tax benefit on stock compensation	594		97
Proceeds from short-term debt	2,759		3,451
Payment of short-term debt	(2,561)		(11,481)
Net change in factoring and bank overdrafts	(441)		(9,121)
Proceeds from long-term debt	0		3,000
Payment of long-term debt	(17,138)		(20,439)
Debt issuance costs	0		(2,113)
Net cash used in financing activities	(13,807)		(35,684)
Effect of foreign currency rate fluctuations on cash and cash equivalents	(1,544)		552
Net decrease in cash and cash equivalents	(22,633)		(18,357)
Cash and cash equivalents:
Beginning of period	118,829	[1]	93,481
End of period	$ 96,196		$ 75,124	[1]

[1] Derived from the Company’s audited Consolidated Financial Statements at December 30, 2012.